Taiwan FDA registration 17655e7f6c117a138af610baa0b2e890

Taiwan CBT ERBB2/CCP17 Probe (Unsterilized)

TW: 台灣康寶盈 ERBB2/CCP17 探針 (未滅菌)

Taiwan·Risk Class 1·PHARMIGENE, INC.·Registered Sep 11, 2012 – Sep 11, 2017Cancelled

Registration details

Analysis ID: 17655e7f6c117a138af610baa0b2e890

Company information

Manufacturer: PHARMIGENE, INC.
Manufacturer Country: Taiwan, Province of China
Authorized Representative: Taiwan Kangbaoying Biotechnology Co., Ltd

Product details

Intended Use: Limited to the first level identification range of immunopathological histochemical reagents and kits (B.1860) of the Measures for the Administration of Medical Devices.
Product Type (Level 1): B Hematology, pathology, and genetics
Product Type (Level 2): B.1860 Immunopathological histochemistry reagents and kits
Import Information: Contract manufacturing;; Domestic

Dates and status

Registration Date: Sep 11, 2012
Expiry Date: Sep 11, 2017
Cancellation Date: Jun 09, 2015

Cancellation information

Status: Logged out
Reason: 自請註銷

About this record

Access comprehensive regulatory information for Taiwan CBT ERBB2/CCP17 Probe (Unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 17655e7f6c117a138af610baa0b2e890 and manufactured by PHARMIGENE, INC.. The authorized representative in Taiwan is Taiwan Kangbaoying Biotechnology Co., Ltd.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.